Iron Deficiency in Patients with Left Ventricular Assist Devices

Iron deficiency is a common and independent predictor of adverse outcomes in patients with heart failure. The implications of iron deficiency
in patients implanted with a left ventricular assist device (LVAD) are less established. This review recaps data on the prevalence, characteristics
and impact of Iron deficiency in the LVAD population. A systematic search yielded eight studies involving 517 LVAD patients, with iron deficiency
prevalence ranging from 40% to 82%. IV iron repletion was not associated with adverse events and effectively resolved iron deficiency in most
patients. However, the effects of iron deficiency and iron repletion on post-implant survival and exercise capacity remain unknown. Although iron
deficiency is highly prevalent in LVAD patients, its true prevalence and adverse effects may be misestimated due to inexact diagnostic criteria.
Future randomised controlled trials on IV iron treatment in LVAD patients are warranted to clarify the significance of this common comorbidity